We are live on
!
Find out more
TGI
TRV GP IV Portfolio holdings
AUM
$267M
1-Year Est. Return
965.83%
This Fund
S&P 500
This Quarter
Est. Return
-38.94%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
–
AUM
$92.9M
AUM Growth
+$12.7M
(+16%)
Cap. Flow
+$73.1M
Cap. Flow
% of AUM
78.75%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MAZE
Maze Therapeutics
MAZE
|
+$73.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
OPL
WAM
IP
SIA
CFG
EU
PC
ALC
TRV GP IV's Q1 2025 Portfolio in Review
As of Q1 2025, TRV GP IV held 3 positions worth $92.9M, up 16% from $80.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP IV deployed $73.1M of net new capital in Q1 2025, opening 1 new position. Its largest new stake was Maze Therapeutics: 6,073,958 shares worth $66.9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP IV's largest Q1 2025 buy was Maze Therapeutics: 6,073,958 shares worth $66.9M.
- TRV GP IV's ten largest holdings make up 100% of its $92.9M portfolio in Q1 2025.
- TRV GP IV opened 1 new position and closed 0 in Q1 2025.
- TRV GP IV's portfolio value rose 16% quarter-over-quarter to $92.9M.
Based on TRV GP IV's 13F filing for Q1 2025, filed 9 May 2025.